Go to Vaccine Library ⟶

Precision Vaccinations

 / September 28th, 2023

Eliminating fake vaccine news with pharmacist, nurse, and physician review.

Vaccine Breaking News

Sep 28 • 1:02 pm CDT

New Hampshire Mosquito and Tick Bites Cause Rare, Potentially Deadly Diseases

The New Hampshire Department of Health and Human Services, Division of Public Health Services (DPHS) recently announced that the risk for both mosquito- and tick-transmitted infections remains high and urged everyone to prevent bites. This is... READ →
Sep 28 • 9:42 am CDT

COVID-19 Pandemic Could Be Ending

According to data posted by the World Health Organization (WHO), the number of COVID-19 cases and related deaths continues to decrease rapidly. As of September 18, 2023, the WHO's data dashboard indicates a global 54.93% decrease... READ →
Sep 27 • 5:44 pm CDT

$433 Million Funds self-amplifying mRNA COVID-19 Vaccine Candidate

Gritstone bio, Inc. today announced that it was awarded a contract by the U.S. Biomedical Advanced Research and Development Authority (BARDA) to conduct a Phase 2b comparative study evaluating Gritstone's self-amplifying mRNA (samRNA) CORAL vaccine candidate... READ →
Sep 27 • 4:36 pm CDT

Colorado Confirms Another Fatal Plague Case

Recent testing has confirmed a case of plague associated with the death of an Archuleta County resident. The Colorado Department of Public Health and Environment and San Juan Basin Public Health (SJBPH) announced on September 25,... READ →
Sep 27 • 11:34 am CDT

RSV Antibody Protection for Infants Now Orderable

The Minnesota Health Department today confirmed that Beyfortus™ (Nirsevimab) is available to order via the Minnesota Vaccine for Children (MnVFC). Beyfortus is the first U.S. FDA-approved extended half-life monoclonal antibody offering passive immunization to infants to... READ →

More Breaking News

$3 Million Funds Group B Streptococcus Vaccine Candidate

'White Coats' Most Trusted Source for Flu, COVID-19, and RSV Vaccine Information

Novel Rabies Vaccine Candidate Hopes to Eliminate Breakthrough Cases

TB Vaccine Accelerator Council Supports Novel Tuberculosis Vaccine Development

$262.5 Million Funds Outbreak Analytics and Disease Modeling Network

Revised CDC Vaccination Schedule Revealed

Japan Approves Alzheimer’s Disease Therapy

U.S. Buys $32 Million More Japanese Encephalitis Vaccines

Very Few Influenza Detections Last Week

Nipah Virus Confronted by Second-Generation mRNA Vaccine Candidate

Latest Vaccine Breaking News

Influenza viruses 2023 Does Influenza Virus Imprinting Influence Severe Hospitalizations Hospitalized people react differently to influenza virus type and subtype
  • Influenza
US CDC vaccine meeting October 2023 U.S. CDC Committee to Review Various Vaccines ACIP Vaccine review meeting October 25, 2023
  • Polio
Dengue outbreaks 2023 Dengue Outbreaks in 2023 Include South Florida Qdenga dengue vaccine does not require diagnostic tests
  • Dengue
Cholera vaccinations 2023 Cholera Outbreaks Continue Without Ample Vaccine Supply Cholera vaccine demand exceeds production in 2023
RSV vaccine 4th Vaccine Approved for Pregnant Women RSV, Tdap, Influenza, COVID-19 vaccines approved for third trimester vaccinations
mRNA vaccines Does Breast Milk Pass mRNA to Infants Vaccination timing associated with mother to infant mRNA transmission
Lyme disease vaccine 2023 Lyme Disease Vaccine Candidate Leverages mRNA Technology OspA mRNA-LNP vaccine targets Lyme disease causing bacteria
Herpes vaccine 2023 Strategic Plan for Herpes Research Includes Vaccines Herpes Accelerate Development including vaccines
Rabies vaccines 2023 Vaccine Hesitancy Impacts Dogs Too Rabies vaccines approved for dogs in 2023
Polio vaccines 2023 Polio Eradication Misses the Mark in 2023 Global Polio Eradication Initiative 2023 goals are unachievable
COVID-19 vaccines Protein-based Vaccines Reduce COVID-19 Symptoms Vidprevtyn protein based COVID-19 vaccine protect people from SARS-CoV-2 variants without antigen matching
Polio outbreaks 2023 The U.S. and Over 30 Countries At-Risk for Poliovirus United States classified as infected with vaccine-derived poliovirus type 2
Flu detections September 2023 Influenza Detections Remain Few And Far Between WHO Influenza Update N° 453
CDC director 2023 mRNA COVID-19 Vaccination Recommended for Fall/Winter 2023 CDC Director authorizes new mRNA COVID-19 vaccines
US CDC COVID-19 vaccines Pharmacies Included in the Bridge Access Program $317 million to fund Vaccines for Adults
CDC pharmacy 2023 COVID-19 and Flu Shot Coadministration Delivers Positive Results
Dog rabies Dog Bites Can Be Deadly Too
Mpox vaccinations 2023 Can Mpox Vaccines Reduce Transmission or Hospitalization
Virginia 2023 Virginia's Deadly Meningococcal Disease Outbreak
HPV vaccine 2023 Ten Years Later, HPV Vaccination Remains Very Protective
Bird flu vaccine 2023 Is Bird Flu an Imminent Threat
Zika vaccine Zika Infections Escalating in 2023
sexual transmitted disease Vaccination Significantly Protected College Students from Gonorrhea
HPV vaccines 2023 Is One HPV Vaccine Dose Enough Cancer Protection?
WHO vaccine 2023 Three COVID-19 Technology Licensing Agreements Confirmed
Malaria map 2023 Malaria Health Alert Issued by the U.S. CDC
polio outbreaks August 2023 WHO Extends Polio Emergency Three Months
Dengue vaccines 2023 New Dengue Therapeutic Coming Soon
Flu season 2023 trends Flu Season Remains MIA
malaria vaccine 2023 Malaria Vaccine Chemoprevention Significantly Reduces Deaths
$1.4 Billion for NextGen COVID-19 Vaccines and Therapeutics
RSV vaccine 2023 Expecting Mothers Have RSV Prevention Options
Dengue outbreak August 2023 215 Dengue Cases Confirmed in Florida
bird flu vaccine 2023 Human Fatality Confirmed Following Bird Flu (A/H3N8) Infection
Ebola vaccines 2023 Ebola Vaccines Embraced by Healthcare Workers

For more articles, try our search.